May 27, 2025
AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio
May 06, 2025
AbbVie to Present at the Bank of America Securities Healthcare Conference
May 01, 2025
BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"
Apr 29, 2025
RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
Apr 25, 2025
AbbVie Reports First-Quarter 2025 Financial Results
Apr 08, 2025
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
Mar 24, 2025
Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025
Mar 15, 2025
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
Mar 04, 2025
AbbVie to Present at the Leerink Partners Global Healthcare Conference
Mar 03, 2025
AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
Feb 28, 2025
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis
Feb 26, 2025
AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference
Feb 13, 2025
AbbVie Declares Quarterly Dividend
Feb 12, 2025
Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
Feb 06, 2025
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Jan 31, 2025
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
Jan 29, 2025
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans
Jan 24, 2025
Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025
Jan 23, 2025
AbbVie Completes Acquisition of Nimble Therapeutics
Jan 23, 2025
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology